Results 221 to 230 of about 155,549 (248)

CYSTIC FIBROSIS

AJN, American Journal of Nursing, 1963
L, SCHWAB, C B, CALLISON, M P, FRANK
openaire   +2 more sources

Cystic fibrosis

Nature, 1989
M, Farrall, P J, Scambler
openaire   +2 more sources

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

American Journal of Respiratory and Critical Care Medicine, 2021
Edith T Zemanick, Jane C Davies, Ronald L․ Gibson   +2 more
exaly  

Cystic Fibrosis

Postgraduate Medicine, 1957
G E, GIBBS, V M, WILDER, J S, BRODKEY, J B, McANDREW, J, CHRISTENSEN, R H, HUTCHINGS, B B, KUMAR, A T, TUMA, R, REYNOLDS, R A, SHIREY   +9 more
openaire   +2 more sources

Cystic Fibrosis

Scientific American, 1995
M J, Welsh, A E, Smith
openaire   +2 more sources

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions

Proceedings of the National Academy of Sciences of the United States of America, 2020
Alejandro P Comellas, Douglas B Hornick, David A Stoltz   +2 more
exaly  

Cystic fibrosis

Medical Journal of Australia, 1985
openaire   +2 more sources

Cystic fibrosis from the gastroenterologist's perspective

Nature Reviews Gastroenterology and Hepatology, 2016
Chee Y Ooi, Peter R Durie, Ooi Chee Y
exaly  

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine, 2020
Marlene Murris-Espin, Lydie Lemonnier, Clemence Dehillotte   +2 more
exaly  

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

American Journal of Respiratory and Critical Care Medicine, 2013
Jane C Davies, Claire E Wainwright, Mark A Chilvers   +2 more
exaly